BD Celebrates 75 years of U.S. Manufacturing Excellence in Nebraska
BD (Becton, Dickinson and Company) celebrated the 75th anniversary of its manufacturing operations in Columbus, Nebraska. The event highlighted the importance of domestic production for critical medical devices. The Columbus facility, which started in 1949 with 15 employees, now employs 2,100 associates across three locations and one million square feet.
Key points:
- BD Columbus is one of only two remaining large-scale syringe manufacturing sites in the U.S.
- The facility has boosted domestic syringe production by 50% in the first nine months of 2024
- BD has invested $200 million in capital over the last four years in Columbus
- The company recognized long-tenured associates, including two with over 47 years of service
The celebration emphasized BD's commitment to U.S. manufacturing and its role in strengthening the medical supply chain's resilience.
BD (Becton, Dickinson and Company) ha celebrato il 75° anniversario delle sue operazioni di produzione a Columbus, Nebraska. L'evento ha messo in evidenza l'importanza della produzione nazionale per dispositivi medici critici. Lo stabilimento di Columbus, avviato nel 1949 con 15 dipendenti, ora occupa 2.100 associati in tre sedi e si estende per un milione di piedi quadrati.
Punti chiave:
- BD Columbus è uno dei soli due restanti siti di produzione di siringhe su larga scala negli Stati Uniti.
- Lo stabilimento ha aumentato la produzione nazionale di siringhe del 50% nei primi nove mesi del 2024.
- BD ha investito 200 milioni di dollari di capitale negli ultimi quattro anni a Columbus.
- La compagnia ha riconosciuto i collaboratori con lunga carriera, inclusi due con oltre 47 anni di servizio.
La celebrazione ha sottolineato l'impegno di BD nella produzione negli Stati Uniti e il suo ruolo nel rafforzare la resilienza della catena di fornitura medica.
BD (Becton, Dickinson and Company) celebró el 75.º aniversario de sus operaciones de fabricación en Columbus, Nebraska. El evento destacó la importancia de la producción nacional para dispositivos médicos críticos. La instalación de Columbus, que comenzó en 1949 con 15 empleados, ahora emplea a 2,100 asociados en tres ubicaciones y abarca un millón de pies cuadrados.
Puntos clave:
- BD Columbus es uno de los dos únicos sitios restantes de fabricación de jeringas a gran escala en EE. UU.
- La instalación ha aumentado la producción nacional de jeringas en un 50 % en los primeros nueve meses de 2024.
- BD ha invertido 200 millones de dólares en capital durante los últimos cuatro años en Columbus.
- La empresa reconoció a asociados de larga trayectoria, incluidos dos con más de 47 años de servicio.
La celebración enfatizó el compromiso de BD con la fabricación en EE. UU. y su papel en el fortalecimiento de la resiliencia de la cadena de suministro médico.
BD (벡톤, 딕슨 앤드 컴퍼니)는 네브래스카주 콜럼버스에서의 제조 운영 75주년을 기념했습니다. 이번 행사는 주요 의료 기기의 국내 생산 중요성을 강조했습니다. 1949년에 15명의 직원으로 시작한 콜럼버스 시설은 현재 세 개의 지역에서 2,100명의 직원이 근무하고 있으며, 총 면적은 100만 평방피트에 달합니다.
주요 사항:
- BD 콜럼버스는 미국 내에서 고속 주사기 제조를 위한 두 개 남은 대규모 제조 장소 중 하나입니다.
- 이 시설은 2024년 첫 아홉 달 동안 국내 주사기 생산을 50% 증가시켰습니다.
- BD는 지난 4년 동안 콜럼버스에 2억 달러의 자본을 투자했습니다.
- 회사는 47년 이상 근속한 두 명의 직원 등을 포함하여 장기 근속자에게 감사의 뜻을 전했습니다.
이번 기념행사는 BD의 미국 제조에 대한 헌신과 의료 공급망의 회복력 강화를 위한 역할을 강조했습니다.
BD (Becton, Dickinson and Company) a célébré le 75e anniversaire de ses opérations de fabrication à Columbus, Nebraska. L'événement a mis en avant l'importance de la production nationale pour les dispositifs médicaux critiques. L'établissement de Columbus, qui a démarré en 1949 avec 15 employés, emploie désormais 2 100 associés répartis sur trois sites et s'étend sur un million de pieds carrés.
Points clés :
- BD Columbus est l'un des deux seuls grands sites restants de fabrication de seringues aux États-Unis.
- Ce site a augmenté la production nationale de seringues de 50 % au cours des neuf premiers mois de 2024.
- BD a investi 200 millions de dollars en capital au cours des quatre dernières années à Columbus.
- L'entreprise a reconnu des associés de longue date, y compris deux ayant plus de 47 ans d'ancienneté.
La célébration a souligné l'engagement de BD envers la fabrication aux États-Unis et son rôle dans le renforcement de la résilience de la chaîne d'approvisionnement médicale.
BD (Becton, Dickinson and Company) feierte das 75-jährige Bestehen seiner Produktionsstätten in Columbus, Nebraska. Die Veranstaltung hob die Bedeutung der nationalen Produktion für kritische medizinische Geräte hervor. Die Columbus-Anlage wurde 1949 mit 15 Mitarbeitern gegründet und beschäftigt heute 2.100 Mitarbeiter an drei Standorten auf einer Fläche von einer Million Quadratfuß.
Wichtige Punkte:
- BD Columbus ist einer von nur zwei verbleibenden großen Herstellungsstandorten für Spritzen in den USA.
- Die Einrichtung hat die nationale Spritzenproduktion in den ersten neun Monaten des Jahres 2024 um 50 % gesteigert.
- BD hat in den letzten vier Jahren 200 Millionen Dollar in Kapital nach Columbus investiert.
Die Feier unterstrich das Engagement von BD für die Produktion in den USA und deren Rolle bei der Stärkung der Resilienz der medizinischen Lieferkette.
- None.
- None.
Emphasizes Value of Domestic Production of Critical Medical Devices
The milestone was celebrated in a ceremony recognizing the achievements of the site and its 2,100 employees. Alongside BD business leaders were
"It's critical we support domestic manufacturing like BD's facility in
"We are incredibly proud of the people of
BD
"For 75 years,
The company's rich history in
As part of the celebration, BD recognized their longest tenured associates in
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Fallon McLoughlin | Adam Reiffe |
BD Public Relations | BD Investor Relations |
201.258.0361 | 201.847.6927 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-celebrates-75-years-of-us-manufacturing-excellence-in-nebraska-302228714.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
How long has BD been manufacturing in Columbus, Nebraska?
How many employees does BD have in Columbus, Nebraska?
What is the significance of BD's Columbus facility for U.S. medical supply production?
How much has BD (BDX) invested in its Columbus operations recently?
What recent production increase has BD (BDX) achieved at its U.S. manufacturing sites?
